-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Guardant Health, Raises Price Target to $135

Benzinga·12/11/2025 21:08:30
Listen to the news
Citigroup analyst Patrick Donnelly maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $100 to $135.